Pharmaceutical Sciences | Test and Evaluation
MRIGlobal is in the drug-testing business.
We analyze human biological fluids for Phase 1 clinical studies to determine the chemical quantities in them. For animal models, we provide full suite testing to establish kinetic profiles.
Our team approaches bioanalytical method validation and sample analysis with strict adherence to quality control assessment, such as routine use of system blanks and matrix evaluation precision-and-accuracy samples. Preliminary studies may be conducted as non-GLP followed by definitive GLP studies with all requisite parameters including long-term stability.
What we test
MRIGlobal’s team can test a drug at all stages, including half-life, peak at maximum concentration, and leaving the body in humans, dogs, cats, and more. We provide quantitative analysis at optimal levels of detection and quantitation in various biological matrices.
Our chemists create reports to inform clients of purity, impurity, potency, short- and long-term stability, and drug profile.
We can create a step-by-step plan for your team to execute on future projects to ensure accuracy and efficiency.
Do we formulate something for oral ingestion, like a capsule? Or should it be a cream? We can make recommendations on how best to formulate a drug or compound for maximum effects.
With 50 years of combined experience including method development, optimization, and validation, our team brings the passion and care necessary for sensitive projects.
We are skilled in handling drugs of abuse, investigational drugs, APIs, small molecule, peptide, and proteins. Our scientists are subject matter experts who provide exemplary service in troubleshooting, solving complex problems, and delivering meaningful data to our customers.
Work with us
MRIGlobal looks forward to contributing our expertise where it matters most.
Use our Project Quote Tool to learn more about how we can help with your next endeavor.